▶ DMSO The Horse vs — a 6-minute, plain-English explainer.
70,000+
Patients Studied Before the Halt
~1,500 US physicians had safety/efficacy data in hand when the FDA froze all DMSO trials, Nov 10, 1965
$0
Patent Owner
DMSO is a 160-year-old, unpatentable molecule — no company will fund the ~$100M in trials modern FDA approval requires for an unownable drug
1971
Approved in Russia (Dimexide)
registered pharmaceutical for sprains, edema, joint inflammation, thrombophlebitis — still on Russian pharmacy shelves today
$10-25
Bottle Cost, OTC in the US
pharma-grade gel or liquid — nobody profits from you buying this over a patented drug
DMSO isn't one thing with one verdict, and it isn't a US-only story. The strength of the evidence depends on what you're using it for and which country's data you're looking at. Some uses are FDA-approved and controlled-trial-backed. Some are decades of standard practice — in US cancer wards, in Russian and German pharmacies, in horse barns everywhere. The popular US home use — rubbing it on a sore joint by itself — sits behind a formal-trial gap that has more to do with 1965 politics and patent economics than with whether it works.
Bladder Condition
Interstitial cystitis — FDA-approved + a 2025 meta-analysis of 554 patients
Russia & Germany
Dimexide (Russia, since 1971) is a registered joint/sprain/edema drug; DMSO ointments are pharmacy staples in both countries
Cancer Care, Vet & Carrier (US)
Chemo-leak rescue, equine swelling (FDA Domoso), the Pennsaid delivery base — real, used daily
Joint Pain (US, DMSO Alone)
The large modern human pain trials were never funded to completion after 1965 — not "tested and failed"
Four unusual properties explain both why people reach for DMSO and why it gets used in hospitals, barns, and Eastern European pharmacies alike:
Soaks Through Skin
Minutes
DMSO passes straight through skin into the tissue underneath — far faster than ordinary creams. That's its signature trick, and why you can taste garlic minutes after rubbing it on your arm. It's also why it's used as a delivery vehicle to carry real drugs through skin (next cards).
Carries Other Drugs In
Delivery Vehicle
Because it dives through skin so easily, DMSO carries dissolved drugs with it. This is a feature in medicine — the FDA-approved arthritis rub Pennsaid is 45% DMSO precisely to push diclofenac through skin — and a hazard at home, because it also carries dirt and contaminants in.
Calms Inflammation & Pressure
Multi-System
Jacob & de la Torre's 2009 pharmacology review documents DMSO lowering intracranial pressure, blocking excess glutamate toxicity, restricting damaging calcium/sodium influx into injured cells, and reducing tissue edema and inflammation — the mechanism behind the bladder relief, the chemo-rescue use, and the sore-joint reports alike.
Mops Up Free Radicals
Antioxidant
DMSO grabs "free radicals" — unstable molecules that damage cells. This is why it was first studied for organ preservation and tissue injury, why it's classed as a free-radical scavenger in veterinary medicine, and why researchers keep revisiting it for swelling and trauma.
DMSO has been used in people and animals for 60+ years, on multiple continents. Here's the full picture — what's FDA-approved, what's standard practice in the US and abroad, and what's genuinely still an open question. The popular home use is at the bottom because that's where the formal US trial record is thinnest, not because the compound is fringe or because it was tested and found wanting.
| # |
Use / Evidence |
How Given |
Where It Stands |
| 1 |
Interstitial cystitis (chronic bladder pain)
|
Into the bladder (by a doctor) |
PROVEN — FDA-approved + meta-analysis |
| 2 |
Sprains, edema, joint inflammation & thrombophlebitis (Russia)
|
Topical gel/ointment |
REGISTERED DRUG (RUSSIA, since 1971) |
| 3 |
Chemotherapy leaks (anthracycline extravasation)
|
On the skin, by nurses |
STANDARD CLINICAL USE (US) |
| 4 |
Veterinary swelling & trauma (dogs & horses, worldwide)
|
On the skin / IV by a vet |
FDA-APPROVED (VETERINARY) + GLOBAL PRACTICE |
| 5 |
Carrier for arthritis medicine (Pennsaid)
|
On the skin |
FDA-APPROVED AS DELIVERY BASE |
| 6 |
Skin & connective-tissue (scleroderma, ulcers, burns)
|
On the skin |
RESEARCHED — promising, off-label |
| 7 |
Brain & spinal-cord injury (raised pressure)
|
IV / experimental |
RESEARCH-STAGE, unfunded past preclinical |
| 8 |
Everyday joint & muscle pain (DMSO by itself, US)
|
On the skin (the popular use) |
FORMAL US TRIALS STALLED, not disproven |
The US formal-approval gap on human pain looks very different once you leave the US. Multiple health systems studied and registered the same molecule for the same use.
Russia: Dimexide, Since 1971
Registered Rx
DMSO was approved for medical use in the USSR/Russia in 1971 under the name Dimexide, indicated for bruises, sprains, edema of various causes, lymphostasis, burns, phlegmon, joint hemorrhage, acute and chronic thrombophlebitis, and erysipelas. It remains a widely used pharmacy product in Russia today, formulated as anti-inflammatory gels and ointments.
Germany: Discovery & Continued Use
Origin Country
DMSO was first isolated in Germany in the 1860s as a wood-pulp/paper byproduct. Pharmaceutical-grade DMSO (USP/Ph.Eur.) remains a regulated ingredient in approved European pharmaceutical products and medical devices, sold under the European Pharmacopoeia standard alongside the US Pharmacopeia one.
UK / Europe: Equine Evidence Reviews
Vet Journals
European veterinary journals, not just American ones, have published formal evidence reviews on DMSO as a topical and intra-articular anti-inflammatory in horses — treating it as a mainstream agent worth a rigorous literature review, not a fringe folk remedy.
Japan: Official Approval, Same Use as US
Post-Approval Data
Japan officially approved intravesical DMSO for Hunner-type interstitial cystitis, and real-world post-approval outcome data from Japanese clinics has since been published — another health system independently reaching the same conclusion the US bladder approval reached.
The contrast that matters. When the US regulatory record is thin on a use, that's often read as "the science says no." Here it isn't — it's "the 1965 halt plus a molecule nobody can patent stalled the American paperwork." Russia registered essentially the identical joint/sprain/inflammation use in 1971, six years after the US halt, and never stopped selling it. Germany, where the compound was discovered, still regulates it as a legitimate pharmaceutical ingredient. That gap between "the US didn't finish testing it" and "it doesn't work" is the whole story here.
For everyday joint and muscle pain — the reason most people try DMSO at home — here's how it stacks up on price. DMSO is the cheapest option on this list by a wide margin, and it is the one option nobody has a financial incentive to fund into a modern blockbuster.
Cheapest, No Sponsor
DMSO (topical)
$10-25
per bottle, lasts weeks
Over the counter
Unpatentable — nobody profits from you buying this
Most Formally Studied OTC
Diclofenac Gel (Voltaren)
$12-30
per tube, OTC
FDA-approved for arthritis pain
Rub-on anti-inflammatory, patent-funded trial base
Oral NSAIDs (ibuprofen, etc.)
$5-15
per bottle, OTC
FDA-approved, well-studied
Stomach/kidney risk with heavy use — DMSO carries no such organ-toxicity profile
Cortisone Injection
$50-250
per shot, often covered
1-3 shots / year
Fast relief, doctor-administered, evidence-backed
Doctor Only
Rimso-50 (bladder, prescription)
Rx
in-clinic, for cystitis
The FDA-approved DMSO
Put into the bladder by a urologist
Why a compound this cheap stays stuck in "unproven." Modern FDA approval for a new indication runs into the tens to hundreds of millions of dollars in required trials. That money is normally recouped through 15-20 years of patent-protected pricing. DMSO went off-patent decades ago and was never patentable for its medical use in the first place — there is no company on Earth with a financial reason to spend $100M+ proving a $15 bottle works better than a $30 patented gel. "No modern US phase-3 trial" reads, to most people, as "it doesn't work." The honest read is "nobody with the money had a reason to find out formally, and the one country that tried (1965 US) got spooked by an unrelated animal-safety scare and never finished."
This is the off-label, do-it-yourself side in the US — not FDA-approved for humans outside the bladder use, and not medical advice. Because DMSO soaks through skin and carries things in with it, the "how" matters a lot for safety. Here's what people commonly do and the rules that keep it from going wrong.
Grade
99.9% pharma only
Use pharmaceutical-grade ("99.9% pure," USP or Ph.Eur.) ONLY. Industrial-grade DMSO can carry impurities straight into your bloodstream. This is the single most important rule.
Dilution
50-70% strength
Water it down before skin use — full strength burns and irritates. A common mix is 7 parts DMSO to 3 parts distilled water (70%). Gels usually come pre-diluted.
Clean Skin
Wash first
Apply only to clean, dry skin — no lotion, no residue. Whatever is on your skin gets carried inside. Thin layer; never on broken skin or open wounds.
Patch Test
24 hours first
Test a small spot 24 hours before full use. Watch for excessive redness, blistering, or intense burning. Expect a garlic-like taste/breath/body odor — that's normal and harmless, just unpleasant.
Don't Inject It
IV is for vets & trials
IV DMSO is real — in veterinary medicine and historic human research — but it belongs to professionals with sterile, dosed, monitored protocols. Self-injecting DMSO or IV "cocktails" at home is genuinely dangerous. Topical only for DIY use.
Important context the headlines miss: DMSO isn't an untested folk remedy. It was one of the most heavily studied compounds of the 1960s — then a regulatory halt and a patent problem, not a failed trial, sidelined the American human-pain research. Here are the real physician-researchers behind it, set against what the controlled literature shows, and what a modern independent clinician voice says today.
Dr. Stanley W. Jacob
MD · Surgeon, OHSU · "Father of DMSO" (1924–2015)
An organ-transplant surgeon who introduced DMSO to medicine in 1963, ran the studies behind the FDA bladder approval, treated thousands of patients, and co-authored the academic textbook "DMSO in Trauma and Disease." Spent 50+ years arguing DMSO was a stalled drug, not a failed one — and personally reported the FDA had safety data on 70,000+ patients when it froze trials in 1965.
vs. PubMed: On the bladder use, the controlled literature now agrees with him — the 2025 meta-analysis calls intravesical DMSO a standard treatment. On the broad pain/anti-inflammatory claims, the modern US controlled-trial record never caught up, though Russia's registered Dimexide and Jacob's own 2009 review with de la Torre document the same mechanism.
Dr. Jack C. de la Torre
MD, PhD · Neuroscientist · CNS-trauma researcher
Ran the 1973 primate research showing DMSO lowered intracranial pressure and improved outcomes after experimental brain compression, then co-authored a 2009 pharmacology review with Jacob documenting DMSO's effects on cerebral blood flow, glutamate toxicity, calcium/sodium influx, and tissue edema across cardiac and CNS injury. The serious science behind "DMSO for brain injury."
vs. PubMed: The animal data are striking and reproducible across multiple decades of his own follow-up work; large human CNS-trauma trials were never funded to completion, so this stays research-stage in people — promising, not disproven.
Independent Clinician Voices (Substack/Reader-Direct Medicine)
MD-authored independent health writing — not pharma- or journal-funded
Physician-authored independent outlets (e.g., "A Midwestern Doctor") argue DMSO is a genuinely effective, very safe therapy for chronic pain, musculoskeletal injury, and even brain/spinal trauma, and that the FDA's decades-long cold shoulder reflects the 1965 panic and patent economics more than a real safety or efficacy problem. They make no money whether or not you buy DMSO — no drug-company sponsorship, no patent stake.
vs. PubMed: Their mechanistic claims track the Jacob/de la Torre literature closely; their "why isn't this mainstream" argument tracks the documented 1965 halt and patent-economics record. Weigh the argument on the evidence, same as any source.
Establishment Skeptic Position (for balance)
McGill University Office for Science and Society
Represents the conventional academic-medicine position: that DMSO's broader healing reputation outran its formal human evidence, that most positive human data comes from uncontrolled cohort studies, and that the "persecuted miracle drug" narrative arguably grew stronger because of the FDA fight, not because of new proof. A real, honestly-held position — presented here as one camp's read, not the page's verdict.
vs. the record: Correct that the modern controlled-trial base for standalone joint pain is thin. Understates that the reason it's thin is a documented regulatory halt plus a molecule nobody can patent — not a completed trial program with a negative result.
~70,000 Patients, Then Halted
Nov 10, 1965
By 1965 the FDA had safety/effectiveness data on more than 70,000 patients from ~1,500 physicians. Then it halted all DMSO trials over an animal eye-lens finding that was never confirmed in humans at normal doses — and the timing coincided with the thalidomide-birth-defect panic, which made the agency broadly risk-averse to any pending new-drug application. Research only resumed after a favorable National Academy of Sciences review in 1972, and the human-pain trials were never re-funded to completion.
Why It's Unpatentable
Since the 1860s
DMSO was first made in Germany in 1866 as a wood-pulp byproduct — it is a 160-year-old commodity chemical, not a novel molecule anyone can own. No company can lock in 15-20 years of exclusive pricing to recoup the ~$100M modern trial cost, so no company has ever picked up the human-pain approval where the 1965 halt left off. This is a patent-economics story, not a science story.
60 Minutes, 1980
70M Viewers
CBS's 60 Minutes ran "The Riddle of DMSO" with Mike Wallace on March 23, 1980 — an estimated 70 million viewers. It covered athletes, doctors, and patients using DMSO for pain and injury, and the FDA standoff. A mainstream-medicine conversation, not a fringe one, that the halt never resolved.
The FDA and NIH are the loudest voices in English-language search results on this topic — but they are one country's regulators, presenting one position, not a global verdict. Read all of them and weigh the contrast.
FDA (US) — Human
Approved for the bladder
Approved 1978 as Rimso-50 for interstitial cystitis, instilled into the bladder by a doctor. Not formally approved for human pain, arthritis, or general skin use — a gap traceable to the 1965 trial halt and the lack of any company willing to fund a modern approval for an unpatentable drug, not to a completed negative trial.
FDA (US) — Veterinary
Approved for dogs & horses
Approved 1970 as Domoso for topical treatment of acute swelling due to trauma in dogs and horses — a full, separate FDA drug approval that long predates the human one. Prescription-only.
Russian Ministry of Health
Approved for joint/skin inflammation since 1971
Dimexide (DMSO) has been a registered prescription drug in Russia since 1971 for sprains, edema, joint hemorrhage, thrombophlebitis, and related inflammatory conditions — essentially the same use the US never finished testing formally. A different regulator reached a different conclusion on identical evidence.
NIH (NCCIH), US
Joint pain: modern evidence insufficient
For osteoarthritis, NCCIH concludes the modern controlled-trial evidence isn't strong enough to formally recommend DMSO (or MSM). This reflects the size of the US trial record, which the 1965 halt and the patent gap left thin — not a completed research program that found no effect.
"So it works on horses, and in Russia, but not on American people?" — not quite. It's the same molecule doing the same anti-inflammatory thing in a horse's leg, a Russian patient's sprained ankle, and a human knee; there's no biological wall where DMSO stops working when it touches an American. The reason it's approved for animals and for Russians but not formally for American human pain is regulatory and economic, not biological: veterinary approval clears a lower evidence bar; Russia's health system reached its own conclusion in 1971; and the US human-pain trials were never finished after the 1965 halt because DMSO is unpatentable — no company will fund the ~$100M studies for a drug it can't own. So "not FDA-approved for human pain" mostly means the American formal trials were never completed — a very different thing from "tested and found useless."
DMSO has a genuinely long, low-toxicity safety record — 60+ years across human medicine, veterinary medicine, and industrial handling — and it has real cautions that come directly from its skin-penetrating, drug-carrying nature. Both of those things are true at once: this is a low-risk compound with a specific, well-understood hazard profile, not a dangerous drug and not a risk-free one.
Common & harmless
Garlic taste/breath/body odor (near-universal), skin warmth, redness, itching or a dry/scaly patch at the application site. Annoying, not dangerous. Diluting and patch-testing reduces the skin reactions.
The carrier risk
Because it pulls whatever's on your skin into you, industrial-grade DMSO can deliver contaminants to your bloodstream, and it can change how your other medications are absorbed. If you take any prescription drug, ask a doctor or pharmacist first.
Who should avoid it
Pregnant or breastfeeding women should not use it. People with liver, kidney, heart, or eye disease should only use it under medical guidance. Never put it on broken skin, and never self-administer it by IV.
The safety math, plainly: across decades of human bladder treatment, veterinary use in millions of animals, and off-label human use, the pattern that emerges is low-toxicity with a specific, manageable carrier hazard — not organ damage, not overdose danger, not the kind of risk profile that would justify fear-based framing. The bladder-instillation trials that anchor the FDA approval report side effects as "mostly mild and acceptable" even at 37% incidence. The dangers of DMSO are mostly about what it carries and how you use it, not the molecule itself. Pharmaceutical grade (99.9%), diluted, on clean skin, not layered over other chemicals, never injected at home — follow those and the downside of trying it is genuinely low. That low downside is itself part of the honest picture, not a reason to hedge it away.
New to DMSO? Start Here.
DMSO is a cheap, clear liquid that started life in Germany as a byproduct of making paper, in 1866. Its one trick: it soaks straight through skin in minutes — and carries whatever it touches along with it. It's FDA-approved in the US for two things (a human bladder condition and animal swelling), used in American cancer wards to rescue chemo leaks, used daily by horse vets on multiple continents, and it has been a registered prescription anti-inflammatory in Russia since 1971 for the exact sore-joint use Americans do off-label at home. The reason it isn't formally approved for that same use in the US traces to a 1965 trial halt and the fact nobody can patent it — not to a completed test that found it doesn't work. Here's the honest tour.
What it is
A simple sulfur-based liquid (dimethyl sulfoxide), first made in Germany in 1866 as a leftover of the wood-pulp/paper industry. Clear, nearly odorless, dirt cheap, unpatentable. Its medical side was discovered by Dr. Stanley Jacob in 1963.
What it's used for
Proven: bladder pain (into the bladder) and animal swelling. In practice, worldwide: chemo-leak rescue, the carrier in an arthritis rub, equine care, and Russia's registered Dimexide for sprains/joint inflammation since 1971. Research-stage: brain-injury swelling. Popular in the US but formally unfinished: sore joints alone.
How people use it
At home, most rub a diluted (50-70%) pharma-grade liquid or gel on a sore spot, on clean skin, after a patch test. The medical versions are different: into the bladder, or applied by professionals. Never inject it yourself.
Is it legal?
Yes, to buy, worldwide. It's sold over the counter as a solvent in the US, and as a registered pharmacy drug in Russia and parts of Europe. It's FDA-approved only for the bladder use (people) and trauma swelling (animals) in the US. Home skin use for pain is legal-to-own but off-label in the US — purity is on you.
The math on trying it
Low, well-documented downside (see the safety section) at a cost of $10-25. This page won't decide for you, but the honest framing is permissive: a decades-long low-toxicity record, a real biological mechanism, and international registered use for this exact purpose make "there's little reason not to try it, carefully" a fair, evidence-based statement — not hype. Pharma grade only (99.9%), dilute, clean skin, patch-test, never injected. Talk to a doctor if you take other meds.
Common Questions, Honest Answers
The questions people actually ask about DMSO — answered plainly, without hype or hand-waving in either direction.
Wait — is it FDA-approved or not?
Both, depending on what for. It has a human approval (Rimso-50, 1978, for interstitial cystitis) and a separate veterinary approval (Domoso, 1970, for swelling in dogs and horses). It is not formally approved for human joint/muscle pain in the US. "Not approved for pain" and "not approved for anything" are very different — the second one is wrong.
Does it actually work for joint and muscle pain?
The US controlled-trial record on DMSO by itself is thin — NIH says the modern evidence isn't strong enough to formally recommend it for arthritis. But that thinness has a documented cause (the 1965 halt, no patent sponsor) rather than a completed negative trial program, and Russia has run the identical use as a registered drug for over 50 years. Notably, the one place DMSO is FDA-approved for joint pain is as the carrier in Pennsaid, where the diclofenac is the FDA-recognized active ingredient in that specific trial design.
It's approved for horses and in Russia — so why "not proven" in the US?
This is the part that trips everyone up, and the answer isn't "it stops working when it crosses the US border." It's the same molecule, same anti-inflammatory mechanism in a horse's leg, a Russian patient's ankle, and an American's knee — humans absorb it the same way everywhere (that's the garlic breath). The split is regulatory and economic, not biological: veterinary approval clears a lower bar than human approval; Russia's regulator reached its own conclusion in 1971; and the big modern US human pain trials were never finished — DMSO is unpatentable (no sponsor for the $100M studies), the garlic-breath tell made blinding difficult, and the 1965 FDA halt, amplified by the thalidomide panic, froze the American field. So the honest US status is formally unsettled, not disproven — and it's a status other countries never shared.
People talk about injecting it / IV DMSO. Is that a thing?
It's real in veterinary medicine and in historic human research (de la Torre's brain-injury work used IV DMSO in primates). But IV use belongs to professionals with sterile, dosed, monitored protocols. Self-injecting DMSO or DIY IV mixes is dangerous — don't.
Why does my breath smell like garlic after using it?
Totally normal. Your body breaks DMSO down into a sulfur compound you breathe out. It can last hours and is harmless — just unpleasant. It's the #1 thing first-timers aren't warned about.
If it's so cheap and useful, why isn't it a blockbuster drug in the US?
Follow the money. It's old and unpatentable — first made in 1866 — so no company has a financial reason to fund the $100M+ trials modern FDA approval for a new indication needs; there's no 15-20 years of exclusive pricing to recoup the investment. The garlic-breath side effect also made blinded studies hard (everyone could tell who got the real thing). Add the 1965 trial halt during the thalidomide scare, and the US human-pain approval stayed stalled for six decades — not because it failed a test, but because nobody with the money had a reason to run one. Russia ran its own version of that test anyway and registered the drug in 1971.
Key Takeaways
- Two US FDA approvals, not one — human interstitial cystitis (Rimso-50, 1978) and veterinary swelling in dogs/horses (Domoso, 1970).
- The bladder use is genuinely proven — a 2025 meta-analysis of 554 patients calls it a standard treatment.
- Registered as Dimexide in Russia since 1971 for sprains, edema, and joint inflammation — the identical use the US home market relies on off-label.
- Real clinical roles beyond that: chemo-leak tissue rescue, the carrier in Pennsaid arthritis gel, and everyday equine medicine on multiple continents.
- The US formal-trial gap on standalone joint pain traces to the 1965 FDA halt (an unconfirmed animal eye finding, amplified by the thalidomide panic) and the fact DMSO is unpatentable — no company has ever funded a modern trial program to finish what 1965 interrupted.
- Its defining trait cuts both ways: it carries other substances through skin — useful in medicine, hazardous with cheap product or dirty skin.
- Decades of use across human medicine, veterinary medicine, and international pharmacy shelves show a genuinely low-toxicity safety record — the real caution is grade, dilution, and never injecting at home, not organ damage.
- Pharma grade (99.9%) only, diluted, clean skin, patch-test, never injected at home. Avoid if pregnant/breastfeeding or on other meds without a doctor's OK.